Trials / Completed
CompletedNCT04225884
Digital Therapeutics (DTx) for Pain: Pilot Study of a Virtual Reality Software for Chronic Pain
DTx for Pain: Behavioural Revalidation in Augmented and Virtual Reality for Chronic Pain; and Exploratory Pilot Study of a Virtual Reality Software
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, randomised, double-blind, 3-arm parallel group comparison of 2 different virtual reality softwares and standard care.
Detailed description
Prospective, randomised, double-blind, 3-arm parallel group comparison of DTx for pain (treatment A), control (treatment B) and an open standard care arm, over 6-8 weeks. An optional adaptive, multi-objective, multi-purpose, extension is included. Study devices will be delivered to the patient's home with instructions for use; patients will receive remote technical support.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | DTx for pain software | Software with active intervention |
| OTHER | Control software | Software without active intervention |
| OTHER | Standard care | Pain medication |
Timeline
- Start date
- 2020-02-04
- Primary completion
- 2023-10-31
- Completion
- 2023-10-31
- First posted
- 2020-01-13
- Last updated
- 2023-11-08
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT04225884. Inclusion in this directory is not an endorsement.